Habre M - Search Results

1

Dermatological manifestations associated with COVID-19 and COVID-19 vaccination: results from the Lebanese COVID registry.

Chrabieh R, Haddad I, Salameh P, Kurban M, Kechichian E, Habre M, Ayoub N, Torbey G, El Sayed F, Maamari M, Tannous Z, Farra A; Lebanese COVID Rash Consortium; El Khoury J. Chrabieh R, et al. Among authors: habre m. Int J Dermatol. 2023 Oct;62(10):1248-1256. doi: 10.1111/ijd.16815. Epub 2023 Aug 28. Int J Dermatol. 2023. PMID: 37638543

2

Health-promoting behaviors and self-efficacy among nursing students in times of uncertainty.

Doumit R, Habre M, Cattan R, Abi Kharma J, Davis B. Doumit R, et al. Among authors: habre m. Worldviews Evid Based Nurs. 2022 Dec;19(6):500-507. doi: 10.1111/wvn.12590. Epub 2022 May 31. Worldviews Evid Based Nurs. 2022. PMID: 35638707

3

Dermatological adverse events associated with immune checkpoint inhibitor-based combinations of anticancer therapies: a systematic review.

Salloum A, Habre M, Chebl JA, Chebl KA, Atallah C, Medawar G, Kourie HR. Salloum A, et al. Among authors: habre m. Immunotherapy. 2022 Apr;14(6):489-503. doi: 10.2217/imt-2021-0244. Epub 2022 Mar 2. Immunotherapy. 2022. PMID: 35232283 Review.

4

Atypical Bullous Pemphigoid After Linagliptin Intake.

Dbouk S, Bazzi N, Saad WA, Toribio A, Habre M, Salloum A. Dbouk S, et al. Among authors: habre m. Am J Case Rep. 2021 Sep 29;22:e932356. doi: 10.12659/AJCR.932356. Am J Case Rep. 2021. PMID: 34584063 Free PMC article.

5

Microneedling in vitiligo: A systematic review.

Salloum A, Bazzi N, Maalouf D, Habre M. Salloum A, et al. Among authors: habre m. Dermatol Ther. 2020 Nov;33(6):e14297. doi: 10.1111/dth.14297. Epub 2020 Sep 23. Dermatol Ther. 2020. PMID: 32940387

6

Implementing an interprofessional education programme in Lebanon: overcoming challenges.

Farra A, Zeenny R, Nasser S, Asmar N, Milane A, Bassil M, Haidar M, Habre M, Zeeni N, Hoffart N. Farra A, et al. Among authors: habre m. East Mediterr Health J. 2018 Dec 9;24(9):914-921. doi: 10.26719/2018.24.9.914. East Mediterr Health J. 2018. PMID: 30570124 Free article.

7

Skin adverse events in recently approved targeted therapies in solid malignancies.

Habre M, Salloum A, Habre SB, Abi Chebl J, Dib R, Kourie HR. Habre M, et al. Future Oncol. 2019 Jan;15(3):331-343. doi: 10.2217/fon-2018-0402. Epub 2018 Dec 7. Future Oncol. 2019. PMID: 30523696 Review.

8

Dermatologic adverse events of checkpoint inhibitors: what an oncologist should know.

Habre M, Habre SB, Kourie HR. Habre M, et al. Immunotherapy. 2016 Dec;8(12):1437-1446. doi: 10.2217/imt-2016-0074. Immunotherapy. 2016. PMID: 28000535 Review.

9

Student perceptions towards interprofessional education: Findings from a longitudinal study based in a Middle Eastern university.

Zeeni N, Zeenny R, Hasbini-Danawi T, Asmar N, Bassil M, Nasser S, Milane A, Farra A, Habre M, Khazen G, Hoffart N. Zeeni N, et al. Among authors: habre m. J Interprof Care. 2016;30(2):165-74. doi: 10.3109/13561820.2015.1117060. J Interprof Care. 2016. PMID: 27026188

10

Facial Scars following Toxic Epidermal Necrolysis: Role of Adnexal Involvement?

Habre M, Ortonne N, Colin A, Meningaud JP, Chosidow O, Wolkenstein P, Valeyrie-Allanore L. Habre M, et al. Dermatology. 2016;232(2):220-3. doi: 10.1159/000443164. Epub 2016 Feb 12. Dermatology. 2016. PMID: 26866828

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

15 results

Search Page